ECSP972008A - COMBINED THERAPY FOR OSTEOPOROSIS - Google Patents

COMBINED THERAPY FOR OSTEOPOROSIS

Info

Publication number
ECSP972008A
ECSP972008A ECSP972008A ECSP972008A EC SP972008 A ECSP972008 A EC SP972008A EC SP972008 A ECSP972008 A EC SP972008A EC SP972008 A ECSP972008 A EC SP972008A
Authority
EC
Ecuador
Prior art keywords
osteoporosis
combined therapy
combinations
bone mass
antagonists
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Hua Zhu Ke
David Duane Thompson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972008 priority Critical patent/ECSP972008A/en
Publication of ECSP972008A publication Critical patent/ECSP972008A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere a una combinación farmaceutica de agonistas/ antagonistas de estrógenos y agentes que estimulan la formación osea e incrementan la masa ósea, estuches que contienen dichas combinaciones y el uso de dichas combinaciones para tratar transtornos que presentan una masa ósea reducida en mamíferos, incluyendo el hombre.This invention relates to a pharmaceutical combination of estrogen agonists / antagonists and agents that stimulate bone formation and increase bone mass, kits containing such combinations, and the use of said combinations to treat disorders of reduced bone mass in mammals, including man.

ECSP972008 1997-01-23 1997-01-23 COMBINED THERAPY FOR OSTEOPOROSIS ECSP972008A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972008 ECSP972008A (en) 1997-01-23 1997-01-23 COMBINED THERAPY FOR OSTEOPOROSIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972008 ECSP972008A (en) 1997-01-23 1997-01-23 COMBINED THERAPY FOR OSTEOPOROSIS

Publications (1)

Publication Number Publication Date
ECSP972008A true ECSP972008A (en) 1998-01-09

Family

ID=42042842

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972008 ECSP972008A (en) 1997-01-23 1997-01-23 COMBINED THERAPY FOR OSTEOPOROSIS

Country Status (1)

Country Link
EC (1) ECSP972008A (en)

Similar Documents

Publication Publication Date Title
AR005987A1 (en) COMBINED THERAPY FOR OSTEOPOROSIS
GT199700141A (en) PREVENTION OF LOSS AND RESTORATION OF THE BONE MASS BY CERTAIN PROSTAGLANDIN AGONISTS.
PT918774E (en) ANDROGENE RECEPTOR MODULATORS AND METHODS
GT199800177A (en) EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE.
BR9811556A (en) Combination therapy comprising atorvastatin and an antihypertensive agent
PT800519E (en) STEROID RECEPTOR MODULATORS AND METHODS
YU18400A (en) Prostaglandin agonists and their use to treat bone disorders
BR9814040A (en) Acute lung with fibrosis with avb6 antagonists
PT92838A (en) DISPENSING DEVICES POWERED BY HYDROGEL
PT1135153E (en) USES FOR ANTAGONISTS AND AGNISTS OF EPH RECEPTORS FOR TREATING VASCULAR DISORDERS
HK1038755A1 (en) Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
ES2196361T3 (en) THERAPEUTIC COMBINATIONS OF RAR ANTAGONISTS AND RXR AGONISTS.
PA8484301A1 (en) PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION
PT951282E (en) PREVENTION AND TREATMENT OF SKELETAL DISEASES WITH SEL2TIVE PROTAGININES E2 AGONISTS OF EP2 RECEPTOR SUBTYPE
PA8452701A1 (en) PROSTAGLANDIN AGONISTS
ES2195382T3 (en) INDOLCARBOXYL COMPOUNDS AND THEIR USE AS PHARMACEUTICAL COMPOUNDS.
BR0105457A (en) Therapeutic combinations to stimulate bone growth
AR003119A1 (en) PHARMACEUTICAL COMPOSITION FOR TREATING VIROSIC INFECTIONS OR INHIBITING THE GROWTH OF TUMORS OR CANCERES WHICH INCLUDE A MIXTURE OF A N-CHLOROPHENYL CARBAMATE OR A N-CHLOROPHENITIC CARBAMATE AND A N- PHOSPHONOGLYCAN FOR DICHAUTIC DURATION INHIBIT THE GROWTH OF TUMORS OR CANCERS
AR016981A2 (en) SYNTHETIC POLYPEPTIDES
MY121054A (en) Calcilytic compounds as calcium receptor antagonists.
IL132853A0 (en) Combination therapy for modulating the human sexual response
ES2173294T3 (en) NEW MEDICAL USE.
BR0208165A (en) Pharmaceutical compositions and their uses in estrogen replacement therapy
CO4230021A1 (en) STEROID GLYCOSIDES, PROCEDURES FOR THE USE OF THESE AS HYPOCHOLESTEROLEMIC AGENTS AND ANTIATEROSCLEROTIC AGENTS IN MAMMALS.
ECSP972008A (en) COMBINED THERAPY FOR OSTEOPOROSIS